HRP970351B1 - Process of preparing phenyl heterocycles useful as cox-2 inhibitors - Google Patents
Process of preparing phenyl heterocycles useful as cox-2 inhibitorsInfo
- Publication number
- HRP970351B1 HRP970351B1 HR970351A HRP970351A HRP970351B1 HR P970351 B1 HRP970351 B1 HR P970351B1 HR 970351 A HR970351 A HR 970351A HR P970351 A HRP970351 A HR P970351A HR P970351 B1 HRP970351 B1 HR P970351B1
- Authority
- HR
- Croatia
- Prior art keywords
- cox
- inhibitors
- preparing phenyl
- phenyl heterocycles
- heterocycles useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2120096P | 1996-07-03 | 1996-07-03 | |
GBGB9615867.0A GB9615867D0 (en) | 1996-07-03 | 1996-07-29 | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP970351A2 HRP970351A2 (en) | 1998-06-30 |
HRP970351B1 true HRP970351B1 (en) | 2003-02-28 |
Family
ID=26309770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR970351A HRP970351B1 (en) | 1996-07-03 | 1997-06-27 | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
Country Status (26)
Country | Link |
---|---|
US (1) | US5840924A (cs) |
EP (1) | EP0912537B1 (cs) |
JP (1) | JP3071472B2 (cs) |
CN (1) | CN1097046C (cs) |
AR (1) | AR007695A1 (cs) |
AT (1) | ATE266651T1 (cs) |
AU (1) | AU717835B2 (cs) |
BR (1) | BR9710099A (cs) |
CA (1) | CA2258048C (cs) |
CZ (1) | CZ297257B6 (cs) |
DE (1) | DE69729096T2 (cs) |
DK (1) | DK0912537T3 (cs) |
EA (1) | EA001629B1 (cs) |
ES (1) | ES2218691T3 (cs) |
GB (1) | GB9615867D0 (cs) |
HK (1) | HK1017355A1 (cs) |
HR (1) | HRP970351B1 (cs) |
HU (1) | HU224840B1 (cs) |
NZ (1) | NZ333379A (cs) |
PL (1) | PL195025B1 (cs) |
PT (1) | PT912537E (cs) |
RS (1) | RS49591B (cs) |
SK (1) | SK283997B6 (cs) |
TW (1) | TW419474B (cs) |
UA (1) | UA57029C2 (cs) |
WO (1) | WO1998000416A1 (cs) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072889A1 (en) * | 1997-04-21 | 2004-04-15 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
EP1061908A4 (en) * | 1998-03-13 | 2007-01-24 | Merck & Co Inc | COMBINATION THERAPY AND COMPOSITION FOR ACUTE CORONARY MIXING SYNDROME AND ASSOCIATED CONDITIONS |
US6031108A (en) * | 1998-09-16 | 2000-02-29 | Bayer Corporation | Process for the preparation of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (TDA sulfone) |
US6649645B1 (en) * | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
WO2001090097A2 (en) * | 2000-05-22 | 2001-11-29 | Dr. Reddy's Research Foundation | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
US20060167074A1 (en) * | 2001-06-19 | 2006-07-27 | Norbert Muller | Methods and compositions for the treatment of psychiatric disorders |
DE10129320A1 (de) * | 2001-06-19 | 2003-04-10 | Norbert Mueller | Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen |
US7049459B2 (en) * | 2001-10-10 | 2006-05-23 | Shasun Chemicals And Drugs Limited | 1-[(4-methyl thio)phenyl]-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same |
AU2003201811A1 (en) * | 2002-01-10 | 2003-07-30 | Pharmacia & Upjohn Company | Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
EP2266585B1 (en) * | 2003-05-07 | 2013-06-26 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
JP4861817B2 (ja) * | 2003-05-07 | 2012-01-25 | オステオロジックス エイ/エス | 軟骨および/または骨の症状の予防および/または治療のためのストロンチウムを用いる併用治療 |
WO2005009342A2 (en) * | 2003-07-16 | 2005-02-03 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
US20050119262A1 (en) * | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
US20050113409A1 (en) * | 2003-09-03 | 2005-05-26 | Pharmacia Corporation | Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith |
WO2006137839A2 (en) | 2004-08-24 | 2006-12-28 | Merck & Co., Inc. | Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
US20060251702A1 (en) * | 2005-05-05 | 2006-11-09 | Cook Biotech Incorporated | Implantable materials and methods for inhibiting tissue adhesion formation |
CN104774186A (zh) * | 2015-04-28 | 2015-07-15 | 江苏中旗作物保护股份有限公司 | 农药除草剂异恶唑草酮的合成方法 |
WO2020106522A1 (en) | 2018-11-21 | 2020-05-28 | Tremeau Pharmaceuticals, Inc. | Purified forms of rofecoxib, methods of manufacture and use |
US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5916884A (ja) * | 1982-07-19 | 1984-01-28 | Fujisawa Pharmaceut Co Ltd | 新規フラン化合物 |
US4968817A (en) * | 1984-07-27 | 1990-11-06 | National Distillers And Chemical Corporation | Manufacture of gamma-crotonolactone by carbonylation of glycidol |
DE3615157A1 (de) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
DE3718527A1 (de) * | 1987-06-03 | 1988-12-15 | Basf Ag | Verfahren zur herstellung von 2(5h)-furanonen |
DE4014420A1 (de) * | 1989-09-23 | 1991-04-04 | Bayer Ag | 5h-furan-2-on-derivate |
US5207817A (en) * | 1989-09-23 | 1993-05-04 | Bayer Aktiengesellschaft | Herbicidal 5H-furan-2-one derivatives |
WO1991016055A1 (en) * | 1990-04-17 | 1991-10-31 | Allergan, Inc. | 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
US5393150A (en) * | 1991-09-05 | 1995-02-28 | Fort; Chris | Bifurcated keyboard arrangement |
IT1254558B (it) * | 1992-03-26 | 1995-09-25 | Mini Ricerca Scient Tecnolog | Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3 |
DK0679157T3 (da) * | 1993-01-15 | 1998-07-27 | Searle & Co | Nye 3,4-diarylthiophener og analoge deraf til anvendelse som antiinflammatoriske midler |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
KR960703901A (ko) * | 1993-08-19 | 1996-08-31 | 로즈 암스트롱 | 치환된 2(5H)푸라논, 2(5H)티오페논 및 2(5H)피롤론 유도체, 그의 제조 방법 및 엔도텔린 길항제로서의 그의 용도(Substituted 2(5H)Furanone, 2(5H)Thiophenone and 2(5H)Pyrrolone Derivatives, Their Preparation and Their Use as Endothelin antagonists) |
CN1143365A (zh) * | 1994-01-10 | 1997-02-19 | 麦克弗罗斯特(加拿大)有限公司 | 作为cox-2抑制剂的苯基杂环类化合物 |
US5475995A (en) * | 1994-05-16 | 1995-12-19 | Livingston; George G. | Truck spare tire locking rod |
-
1996
- 1996-07-29 GB GBGB9615867.0A patent/GB9615867D0/en active Pending
-
1997
- 1997-06-16 US US08/876,894 patent/US5840924A/en not_active Expired - Fee Related
- 1997-06-27 HR HR970351A patent/HRP970351B1/xx not_active IP Right Cessation
- 1997-06-27 NZ NZ333379A patent/NZ333379A/xx not_active IP Right Cessation
- 1997-06-27 PL PL97330750A patent/PL195025B1/pl not_active IP Right Cessation
- 1997-06-27 JP JP10504411A patent/JP3071472B2/ja not_active Expired - Fee Related
- 1997-06-27 DE DE69729096T patent/DE69729096T2/de not_active Expired - Lifetime
- 1997-06-27 CZ CZ0436898A patent/CZ297257B6/cs not_active IP Right Cessation
- 1997-06-27 PT PT97932424T patent/PT912537E/pt unknown
- 1997-06-27 CN CN97196133A patent/CN1097046C/zh not_active Expired - Fee Related
- 1997-06-27 EP EP97932424A patent/EP0912537B1/en not_active Expired - Lifetime
- 1997-06-27 DK DK97932424T patent/DK0912537T3/da active
- 1997-06-27 CA CA002258048A patent/CA2258048C/en not_active Expired - Fee Related
- 1997-06-27 EA EA199900079A patent/EA001629B1/ru not_active IP Right Cessation
- 1997-06-27 HU HU9903836A patent/HU224840B1/hu not_active IP Right Cessation
- 1997-06-27 SK SK1793-98A patent/SK283997B6/sk not_active IP Right Cessation
- 1997-06-27 UA UA99020607A patent/UA57029C2/uk unknown
- 1997-06-27 WO PCT/US1997/011466 patent/WO1998000416A1/en active IP Right Grant
- 1997-06-27 AU AU35886/97A patent/AU717835B2/en not_active Ceased
- 1997-06-27 RS YUP-592/98A patent/RS49591B/sr unknown
- 1997-06-27 AT AT97932424T patent/ATE266651T1/de active
- 1997-06-27 ES ES97932424T patent/ES2218691T3/es not_active Expired - Lifetime
- 1997-06-27 BR BR9710099A patent/BR9710099A/pt not_active IP Right Cessation
- 1997-06-28 TW TW086109096A patent/TW419474B/zh not_active IP Right Cessation
- 1997-07-01 AR ARP970102940A patent/AR007695A1/es active IP Right Grant
-
1999
- 1999-06-08 HK HK99102482A patent/HK1017355A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1017355A1 (en) | Process of preparing phenyl heterocycles useful as cox-2 inhibitors | |
AU3510595A (en) | Process for making phenyl heterocycles useful as cox-2 inhibitors | |
SG43841A1 (en) | Phenyl heterocycles as cox-2 inhibitors | |
IL122186A (en) | Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists | |
GB2308366B (en) | Tri-substituted phenyl derivatives useful as PDE IV inhibitors | |
IL125829A0 (en) | Method of sharing cryptokey | |
PL329276A1 (en) | Substituted benzenezulphonamide derivatives as prodrugs of cox-2 inhibitors | |
PL344108A1 (en) | Process for synthesizing cox-2 inhibitors | |
PL333918A1 (en) | Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors | |
IL122187A0 (en) | Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4-antagonists | |
PL342469A1 (en) | Method of obtaining stilbenic compounds | |
PL331920A1 (en) | Spirocyclic inhibitors of metaloproteases | |
PL329153A1 (en) | Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase | |
EG23819A (en) | Method for preparing of l-phenylephrine-hydrochloride | |
PL333925A1 (en) | Method of obtaining derivatives of thiazole | |
HUP0003155A3 (en) | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors | |
HU9902691D0 (en) | Process for re-esterification of alfa-keto-carboxylic-acid-esters | |
SI0912537T1 (en) | Process of preparing phenyl heterocycles useful as cox-2 inhibitors | |
PL328795A1 (en) | Method of obtaining n-rotected derivatives of d-proline | |
GB9622831D0 (en) | Process for making phenyl heterocycles useful as cox-2 inhibitors | |
GB9622816D0 (en) | Process for making phenyl heterocycles useful as cox-2 inhibitors | |
GB9613110D0 (en) | Process for making phenyl heterocyclic useful as cox-2 inhibitors | |
GB9823420D0 (en) | Process for making phenyl heterocylces useful as cox-2 inhibitors | |
GB9806691D0 (en) | Process for making phenyl heterocycles useful as cox-2 inhibitors | |
EP1038021A4 (en) | COMPOUNDS AND METHODS FOR INHIBITING INTERACTIONS BETWEEN PROTEINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
PNAN | Change of the applicant name, address/residence |
Owner name: MERCK SHARP & DOHME CORP., US |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110621 Year of fee payment: 15 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20120628 |